TNFRSF4 antibody (PE-Cy7)
Quick Overview for TNFRSF4 antibody (PE-Cy7) (ABIN749121)
Target
See all TNFRSF4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse, Rat
-
Predicted Reactivity
- Dog,Cow,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TNFRSF4
-
Isotype
- IgG
-
-
-
-
Application Notes
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Alternative Name
- CD134
-
Background
-
Synonyms: OX4, ACT35, CD134, IMD16, TXGP1L, Tumor necrosis factor receptor superfamily member 4, ACT35 antigen, OX4L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, TNFRSF4
Background: Receptor for TNFSF4/OX4L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity.
-
Molecular Weight
- 30kDa
-
Gene ID
- 7293
-
UniProt
- P43489
-
Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-